You are here

Roche focuses on diagnostics to help cut healthcare costs

It can enable patients to avoid unnecessary treatment in hospitals and reduce duration of their stay there

Mr Little says diagnostics receives only 2% of healthcare funding worldwide although it influences over 60% of treatment decisions.


GIVEN the sweeping trend in Asia - the growing middle class, a rapidly ageing population and an explosion of lifestyle diseases - Roche Diagnostics has pumped money into expanding its diagnostics value chain to help change medical practice and improve quality of care.


Market voices on: